Creative regulatory practices to develop stem-cell technology: the way forward for Malaysia.

Autor:	Bin Abdul Aziz MF; Centre for Law and Ethics in Science and Technology (CELEST), Faculty of Law, Universiti Malaya, Kuala Lumpur, Malaysia.; Centre for Health, Law and Ethics of Emerging Technologies (HeLEX), Faculty of Law, University of Oxford, Oxford, UK., Morrison M; Centre for Health, Law and Ethics of Emerging Technologies (HeLEX), Faculty of Law, University of Oxford, Oxford, UK., Kaye J; Centre for Health, Law and Ethics of Emerging Technologies (HeLEX), Faculty of Law, University of Oxford, Oxford, UK.
Jazyk:	angličtina
Zdroj:	Regenerative medicine [Regen Med] 2022 Feb; Vol. 17 (2), pp. 91-105. Date of Electronic Publication: 2021 Dec 15.
DOI:	10.2217/rme-2021-0068
Abstrakt:	Malaysia aspires to develop regenerative medicine through stem-cell technology. It needs a regulatory system that could facilitate development and prevent unethical practices. A comparative legal analysis on the regulation of stem-cell technology, with a focus on stem-cell research in Malaysia and selected Commonwealth countries that are experienced in regulating this complex technology, demonstrates that the selected Commonwealth countries have adopted a hybrid of different regulatory mechanisms. This paper argues that Malaysia should consider adopting a similar approach to equip relevant authorities with different regulatory mechanisms that are able to promote innovation in stem-cell research activities and cultivate a successful and profitable regenerative medicine industry in the future. Such a strategic action can produce an optimal regulatory outcome and help Malaysia to realize its aspiration.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu